The group’s principle activity is to provide research into the development of stable, broad-spectrum, fast acting antimicrobial technologies has resulted in the creation of multiple “next generation” products for the protection of life and property from microbial threats. The group also provides practical and in-depth scientific education to the public, businesses and healthcare sectors, addressing preparedness for pandemic eventualities, bioterrorist attacks, and the prevention of healthcare-associated infections. The group’s products include T-3000 and T-5000TM. The group operates from United States.
